ATXS logo

Astria Therapeutics (ATXS) Cash From Operations

Annual CFO

-$68.44 M
-$24.91 M-57.23%

December 31, 2023


Summary


Performance

ATXS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXScash flowmetrics:

Quarterly CFO

-$27.96 M
-$11.17 M-66.55%

September 30, 2024


Summary


Performance

ATXS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXScash flowmetrics:

TTM CFO

-$94.09 M
-$13.71 M-17.05%

September 30, 2024


Summary


Performance

ATXS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXScash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ATXS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-57.2%-96.1%-92.5%
3 y3 years-110.7%-96.1%-92.5%
5 y5 years-191.7%-96.1%-92.5%

ATXS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-127.0%at low-344.9%+7.5%-212.1%at low
5 y5-year-157.6%at low-344.9%+7.5%-254.1%at low
alltimeall time-318.2%at low-507.5%+7.5%-1944.1%at low

Astria Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$27.96 M(+66.5%)
-$94.09 M(+17.1%)
Jun 2024
-
-$16.79 M(-12.1%)
-$80.38 M(+8.2%)
Mar 2024
-
-$19.09 M(-36.9%)
-$74.29 M(+8.5%)
Dec 2023
-$68.44 M(+57.2%)
-$30.24 M(+112.1%)
-$68.44 M(+40.1%)
Sep 2023
-
-$14.26 M(+33.3%)
-$48.87 M(+8.9%)
Jun 2023
-
-$10.70 M(-19.3%)
-$44.86 M(+1.4%)
Mar 2023
-
-$13.25 M(+24.3%)
-$44.23 M(+1.6%)
Dec 2022
-$43.53 M(+44.4%)
-$10.66 M(+4.0%)
-$43.53 M(+11.2%)
Sep 2022
-
-$10.25 M(+1.9%)
-$39.16 M(+6.8%)
Jun 2022
-
-$10.06 M(-19.9%)
-$36.66 M(+7.8%)
Mar 2022
-
-$12.56 M(+99.8%)
-$33.99 M(+12.7%)
Dec 2021
-$30.15 M(-7.2%)
-$6.29 M(-18.9%)
-$30.15 M(-5.6%)
Sep 2021
-
-$7.75 M(+4.7%)
-$31.93 M(-6.5%)
Jun 2021
-
-$7.40 M(-15.1%)
-$34.15 M(-0.2%)
Mar 2021
-
-$8.72 M(+8.1%)
-$34.21 M(+5.3%)
Dec 2020
-$32.48 M(+22.3%)
-$8.06 M(-19.1%)
-$32.48 M(+0.9%)
Sep 2020
-
-$9.97 M(+33.5%)
-$32.19 M(+12.2%)
Jun 2020
-
-$7.47 M(+6.8%)
-$28.70 M(+6.4%)
Mar 2020
-
-$6.99 M(-10.1%)
-$26.97 M(+1.5%)
Dec 2019
-$26.57 M
-$7.77 M(+20.0%)
-$26.57 M(+10.4%)
Sep 2019
-
-$6.47 M(+12.8%)
-$24.07 M(+3.0%)
Jun 2019
-
-$5.74 M(-12.9%)
-$23.37 M(+0.6%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$6.59 M(+25.0%)
-$23.23 M(-1.0%)
Dec 2018
-$23.46 M(-12.6%)
-$5.27 M(-8.8%)
-$23.46 M(-1.5%)
Sep 2018
-
-$5.78 M(+3.1%)
-$23.83 M(-6.4%)
Jun 2018
-
-$5.60 M(-17.8%)
-$25.47 M(-0.3%)
Mar 2018
-
-$6.82 M(+21.0%)
-$25.55 M(-4.8%)
Dec 2017
-$26.84 M(-18.3%)
-$5.64 M(-24.0%)
-$26.84 M(-8.0%)
Sep 2017
-
-$7.41 M(+30.5%)
-$29.18 M(+1.8%)
Jun 2017
-
-$5.68 M(-29.9%)
-$28.67 M(-9.9%)
Mar 2017
-
-$8.11 M(+1.5%)
-$31.82 M(-3.2%)
Dec 2016
-$32.86 M(+10.3%)
-$7.98 M(+15.7%)
-$32.86 M(-2.3%)
Sep 2016
-
-$6.90 M(-21.9%)
-$33.62 M(-2.7%)
Jun 2016
-
-$8.83 M(-3.5%)
-$34.55 M(+8.9%)
Mar 2016
-
-$9.15 M(+4.6%)
-$31.71 M(+6.4%)
Dec 2015
-$29.79 M(+46.0%)
-$8.74 M(+11.7%)
-$29.79 M(+10.5%)
Sep 2015
-
-$7.83 M(+30.6%)
-$26.97 M(+13.0%)
Jun 2015
-
-$6.00 M(-17.1%)
-$23.87 M(+3.6%)
Mar 2015
-
-$7.23 M(+22.1%)
-$23.04 M(+12.9%)
Dec 2014
-$20.41 M(+24.7%)
-$5.92 M(+25.2%)
-$20.41 M(+40.9%)
Sep 2014
-
-$4.73 M(-8.4%)
-$14.49 M(+48.4%)
Jun 2014
-
-$5.16 M(+12.1%)
-$9.76 M(+112.1%)
Mar 2014
-
-$4.60 M
-$4.60 M
Dec 2013
-$16.37 M
-
-

FAQ

  • What is Astria Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Astria Therapeutics?
  • What is Astria Therapeutics annual CFO year-on-year change?
  • What is Astria Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Astria Therapeutics?
  • What is Astria Therapeutics quarterly CFO year-on-year change?
  • What is Astria Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Astria Therapeutics?
  • What is Astria Therapeutics TTM CFO year-on-year change?

What is Astria Therapeutics annual cash flow from operations?

The current annual CFO of ATXS is -$68.44 M

What is the all time high annual CFO for Astria Therapeutics?

Astria Therapeutics all-time high annual cash flow from operations is -$16.37 M

What is Astria Therapeutics annual CFO year-on-year change?

Over the past year, ATXS annual cash flow from operations has changed by -$24.91 M (-57.23%)

What is Astria Therapeutics quarterly cash flow from operations?

The current quarterly CFO of ATXS is -$27.96 M

What is the all time high quarterly CFO for Astria Therapeutics?

Astria Therapeutics all-time high quarterly cash flow from operations is -$4.60 M

What is Astria Therapeutics quarterly CFO year-on-year change?

Over the past year, ATXS quarterly cash flow from operations has changed by -$13.71 M (-96.14%)

What is Astria Therapeutics TTM cash flow from operations?

The current TTM CFO of ATXS is -$94.09 M

What is the all time high TTM CFO for Astria Therapeutics?

Astria Therapeutics all-time high TTM cash flow from operations is -$4.60 M

What is Astria Therapeutics TTM CFO year-on-year change?

Over the past year, ATXS TTM cash flow from operations has changed by -$45.22 M (-92.52%)